Elkstone Capital Partners

Elkstone is a Dublin-based multi-family office and venture firm that has become one of the more active early-stage investors in Ireland through its dedicated venture vehicle. The firm manages a one hundred million euro early-stage fund focused on high-growth technology companies, with healthcare software and digital health as recurring themes. Operating across the family office and venture practice gives the firm a long time horizon and a natural role as a patient early investor for Irish founders.

The venture thesis spans business-to-business software, consumer technology, and increasingly digital health and healthcare software. AI-enabled products are a clear focus, including clinical decision support, healthcare operations software, patient engagement tools, and applications layered on top of healthcare data. The firm tends to back ambitious technical founders rather than pure services businesses, and is comfortable with companies that need a few rounds of patient capital before reaching commercial scale.

Investments span Pre-Seed, Seed, and Series A, with checks typically in the one to five million dollar equivalent range. Geographic focus is Ireland with selective activity in the United Kingdom and continental Europe. The fund leads or co-leads at Pre-Seed and Seed and participates at Series A, often working alongside the broader Irish venture ecosystem and selected European specialist investors.

Elkstone operates with a partnership built around its venture practice, drawing on the family office for follow-on capital and broader expertise. The team blends investing backgrounds with operational experience across technology and finance, and engages closely with portfolio companies on hiring and commercial development. Founders should expect a hands-on relationship that reflects the firm’s family office DNA.

The practical value of working with Elkstone is access to one of the deeper sources of early-stage capital in Ireland, with the patience to support founders through the gaps that smaller European markets can produce between rounds. Portfolio companies benefit from introductions across the family office’s broader network, follow-on capacity from later vehicles, and a partner that can help navigate the realities of building a global business from an Irish base, including expansion to the United States and the United Kingdom. The fit is strongest for ambitious Irish or UK-based digital health and healthcare software founders who want a substantive local lead rather than a supporting check, and for technical founders whose roadmap requires patient capital. Companies based outside Elkstone’s geographic focus typically find a closer-to-home fund a more practical primary partner, though Elkstone occasionally participates in deals with Irish operating connections.